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Abstract 
Background: To retrieve all diagnosed cancer 
cases during the past four years (2014-2017) in 
Benazir Bhutto Hospital, Rawalpindi, and categorize 
them by organ sites affected/ topographically, to 
determine cancers with the highest prevalence in our 
part of the world. 
Materials & Methods: A hospital registry-based 
retrospective study was undertaken in the 
Department of Pathology of Benazir Bhutto 
Hospital, Rawalpindi. All diagnosed cases of cancer 
for the past four years that had been histologically 
confirmed, were retrieved. The cancer cases thus 
obtained were then classified topographically, 
according to the International classification of 
diseases for oncology. The data obtained was then 
analyzed using SPSS v.23 into percentage 
frequencies and ranked with respect to gender, and 
presented using tables and figures. 
Results: Urinary Bladder, Breast, Prostate, Skin, 
Kidney, Colorectum, Cervix, Esophagus, Uterus and 
Vulva were in descending order the 10 leading sites 
overall. 
Carcinoma of the Urinary Bladder emerged as the 
leading cancer in males, comprising 30.7% of male 
cases, followed by Prostate (24.7%), Skin (16.3%), 
Colorectum (5.6%), Kidney (5.6%) and Stomach 
(2.4%). 
The most common site of cancer in females was 
Breast (36.2%), followed in decreasing order by 
Cervix (8.6%), Kidney (7.6%), Urinary Bladder (7.1%), 
Skin (7.1%), and Esophagus (6.2%). 
Conclusion: In conclusion, the cancer pattern 
revealed by this study provides valuable leads to 
cancer epidemiology in the region. The two most 
common cancer sites in males were urinary bladder 
(30.7%) and prostate (24.7%), whereas in females 
they were breast (36.2%) and cervix (8.6%). 
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Introduction: 
Cancer is a serious health problem around the globe, 
with an estimated 14.1 million new cases and 8.2 
million deaths annually. Out of these 14.1 million new 
cases, 8 million occurred in the developing countries in 
which about 80% of the world’s population resides. By 
the year 2030, the global cancer burden is expected to 
grow to 21.7 million new cases and 13 million deaths 
annually, mainly due to the growth and aging of 
population.1 However, it is said that the future cancer 
burden will be considerably larger than the current 
estimates because of adoption of lifestyles, such as 
smoking, physical inactivity, poor diet, fewer 
pregnancies, etc. that are believed to increase the risk 
for developing cancer.2,3 
In order to prevent and control cancers, there is an 
overwhelming need to establish and maintain cancer 
registries, which would then assist in formulating an 
effective health policy against the ever increasing 
cancer burden worldwide. The information obtained 
from these cancer registries can be used to look for 
trends over time, to find cancer patterns in certain 
geographical regions or populations, or to determine 
whether screening and other preventive measures are 
making any significant difference. Therefore, registries 
and surveillance information are key parts of cancer 
prevention and control efforts around the globe.4 
The absence of any effective mechanism to collect and 
analyze credible data on prevalence of cancer in 
Pakistan is retarding us from taking appropriate 
measures for the timely diagnosis and treatment of 
this disease. Pakistan bears a significant cancer burden 
with rising trends of risk factors, thereby it is a country 
in dire need of cancer control. 
The rationale behind this study was to retrieve all 
diagnosed cancer cases for the past four years (2014-
2017) in Benazir Bhutto Hospital, Rawalpindi, and 
categorize them by organ sites affected/ 
topographically, to determine cancers with the highest 
prevalence in our part of the world. In the absence of a 
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population based cancer registry in Rawalpindi, this 
study along with previous reports may prove helpful 
in estimating the incidence of different cancers in the 
region. 
 
Materials and Methods: 
 A 4 year hospital registry-based retrospective study 
from January 2014 to December 2017 was undertaken 
in the Department of Pathology of Benazir Bhutto 
Hospital, Rawalpindi, a tertiary care teaching hospital 
affiliated with Rawalpindi Medical University. All 
diagnosed cases of cancers for the past four years 
(2014-2017) that had been histologically confirmed, 
were retrieved. In situ or borderline cancers were 
excluded. A single entry per patient has been made in 
our data even when multiple samples may have been 
examined.  
The cancer cases thus obtained were then classified on 
the basis of organ site affected, i.e. topographically, 
according to the International classification of diseases 
for oncology.5 Each tumor was assigned ICD-O code 
(International Classification of diseases for Oncology), 
published by International Agency for Research on 
cancer (IARC).5 The total number of cancer cases was 
calculated for each year. The data obtained was then 
analyzed using SPSS v.23 into percentage frequencies 
and ranked with respect to gender, and presented 
using tables and figures.  
 
Results: 
During the study period, a total of 461 cases of cancer 
were received of which 251 (54.4%) were males and 
210 (45.6%) were females - sex ratio 1.2: 1 (Fig. I). 
There was an initial decrease followed by a 
progressive increase in the number of cancer cases per 
year during the study period i.e. 2014-2017. Figure II 
demonstrates the trend of cancer incidence over these 
four years of study.  
Table I summarizes the most common malignancies 
according to rank that were seen in both males as well 
as in females. Urinary Bladder, Breast, Prostate, Skin, 
Kidney, Colorectum, Cervix, Esophagus, Uterus and 
Vulva were in descending order the 10 leading sites. 
Cancer of the Urinary Bladder emerged as the leading 
cancer in males comprising 30.7% of male cases 
followed by Prostate (24.7%), Skin (16.3%), 
Colorectum (5.6%), Kidney (5.6%) and Stomach (2.4%) 
as presented in Table II. 
On the other hand the most common site of cancer in 
females was Breast (36.2%), followed in decreasing 
order by Cervix (8.6%), Kidney (7.6%), Urinary 
Bladder (7.1%), Skin (7.1%), and Esophagus (6.2%) as 
shown in Table III. 
 
Fig. I: Percentage Distribution Among Males and 
Females 
 
 
 
 
 
 
 
 
 
 
 
 
Fig II: Cancer Trend 2014-2017 
 
 
TABLE I: Leading Cancer Sites Overall 
     
RANK SITE ICD-
O 
No. OF 
CASES 
PERCENTAGE 
 
1. 
 
Urinary 
Bladder 
 
C67 
 
92 
 
20.0% 
2. Breast C50 76 16.5% 
3. Prostate C61 62 13.4% 
4. Skin C44 56 12.1% 
5. Kidney C64 30 6.5% 
6. Colorectal C18-21 18 3.9% 
7. Cervix C53 18 3.9% 
8. Esophagus C15 18 3.9% 
9. Uterus C54-55 10 2.2% 
10. Vulva C51 10 2.2% 
11. Larynx C32 8 1.7% 
12. Oral 
Cavity 
C00-06 8 1.7% 
13. Stomach C16 8 1.7% 
14. Ovary C56 7 1.5% 
15. Lymph 
Node 
C77 5 1.1% 
16. Pharynx C10-14 4 0.9% 
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17. Testis C62 4 0.9% 
18. Vagina C52 4 0.9% 
19. Other Sites - 23 5.0% 
Total   461 100% 
 
 
TABLE II: Leading Cancer Sites In Males 
            
RANK SITE ICD-O No. OF 
CASES 
PERCENTAGE 
1. Urinary 
Bladder 
C67 77 30.7% 
2. Prostate C61 62 24.7% 
3. Skin C44 41 16.3% 
4. Colorectal C18-21 14 5.6% 
5. Kidney C64 14 5.6% 
6. Stomach C16 6 2.4% 
7. Esophagus C15 5 2.0% 
8. Larynx C32 5 2.0% 
9. Oral 
Cavity 
C0-06 4 1.6% 
10. Testis C62 4 1.6% 
11. Lymph 
Node 
C77 3 1.2% 
12 Pharynx C10-14 3 1.2% 
13. Other Sites - 13 5.2% 
Total   251 100% 
 
TABLE III: Leading Cancer Sites In Females 
     
RANK SITE ICD-O No. OF 
CASES 
PERCENTAGE 
 
1. 
 
Breast 
 
C50 
 
76 
 
36.2% 
2. Cervix C53 18 8.6% 
3. Kidney C64 16 7.6% 
4. Urinary 
Bladder 
C67 15 7.1% 
5. Skin C44 15 7.1% 
6. Esophagus C15 13 6.2% 
7. Uterus C54-55 10 4.8% 
8. Vulva C51 10 4.8% 
9. Ovary C56 7 3.3% 
10. Colorectal C18-21 4 1.9% 
11. Oral 
Cavity 
C0-06 4 1.9% 
12. Vagina C52 4 1.9% 
13. Other Sites - 18 8.6% 
 Total   210 100% 
 
 
 
Discussion: 
Epidemiological information on cancer including the 
incidence pattern is an essential tool for determining 
the priorities for cancer control in any population 
group. There are pronounced disparities in 
distribution of cancers in different regions of the world 
mainly due to differences in the prevailing 
environmental and sociocultural factors. These factors 
contributing to geographic differences include 
variations in the age structure of the population, the 
prevalence of risk factors (e.g., smoking, alcohol 
intake, dietary habits, etc.), the availability and use of 
diagnostic tests (e.g., for cancer screening) and the 
availability and quality of treatment.6,7  
We observed a significant increase in the incidence 
during the study period, which suggests an increase in 
the risk behavior in the population with lifestyle 
changes and deteriorating dietary habits. This 
increased incidence may also be attributed to 
improved diagnostic facilities over the years and 
increased accessibility to these facilities. Whatever 
may be cause of increased incidence, it supports the 
existing predictions of increasing cancer incidence and 
mortality in developing countries as the population 
continues to expand. It must be stated here that the 
number of cases retrieved in this study is actually an 
underestimation of the actual cancer burden in the 
region as our hospital is not the only tertiary care 
hospital in the region and also because the absence of 
an oncology unit in our hospital does not make it a 
natural choice of referral for cases having a high 
suspicion of malignancy. In addition, we may also be 
missing cases with advanced malignancies who may 
not be subjected to intense diagnostic procedures, 
older patients or females who may not be entering the 
health sector and the socio-economically deprived who 
may not have access to medical care. 
Global cancer trends demonstrate a slight male 
predominance, also observed in our study with a male: 
female ratio of 1.2:1.6 The exact reason for this male 
preponderance is still unclear but it is believed that 
increased exposure to risk factors (e.g. smoking and 
alcohol consumption) in males, may be the underlying 
cause.   
In our study, cancer of the urinary bladder came out to 
be the most common cancer overall, as well as in men 
comprising 30.7% of all male cases. In females it 
accounted for about 7.1% of all cases making it the 
fourth most common cancer in females. The wide sex 
ratio (male: female) exhibited in our study is in line 
with numerous international studies observing male 
predominance in cases of bladder cancer.6,8 There  is 
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about 15 fold variation in incidence rates of bladder 
carcinoma internationally, partly due to differences in 
the reporting of low grade urinary bladder tumors (i.e. 
malignant but noninvasive).9 Smoking is the most 
established risk factor and is said to increase the risk of 
bladder carcinoma by two to six fold and cause about 
31% of bladder cancer deaths among males and 14% 
among females worldwide.10,11 In this study urothelial 
carcinomas were far more prevalent than the 
squamous cell type which is associated with 
schistosomiasis and makes up about 3% of cases 
worldwide.12 
The second most common cancer in men was that of 
prostate accounting for 24.7% of all male cases. 
Globally it is the second most frequently diagnosed 
cancer in men.6 Annual cancer registry report of 
Shaukat Khanum Cancer Hospital for the year 2016 
stated colorectum and prostate as the leading cancer 
sites in men.13 A couple of local studies carried out in 
Rawalpindi and Hazara division regard prostate 
cancer as the first and third most common cancer 
among males respectively.14,15  The risk factors proven 
to be associated with prostate cancer are old age, 
family history and inherited genetic conditions. 
According to recent studies smoking is associated with 
prostate cancer death but not incidence.16  
Breast cancer, the leading female cancer worldwide 
was the most common cancer among females making 
up 36.2% of all female cases. In almost all the local 
studies carried out in various regions of Pakistan, 
breast cancer was invariably the most common cancer 
in females.13-15, 17-20 Most of the cases of breast cancer in 
our study were of invasive ductal type. The high 
prevalence of breast cancer worldwide has been linked 
to reproductive factors, obesity, physical inactivity and 
changes in diet and lifestyle.21-23 Early detection and 
treatment in developed countries has kept mortality 
from breast cancer under control. However in 
developing countries like ours, there is an urgent need 
to develop effective screening mechanisms for the 
early detection and subsequent treatment of breast 
cancer. Developing health programmes that promote 
breast self-examination, clinical breast examination, 
and FNAC along with mammographic screening may 
prove helpful.24 
Cervical cancer was the second most common cancer 
in females comprising 8.6% of total female cases. 
Globally it is the fourth most commonly diagnosed 
cancer in females with particularly high prevalence in 
developing countries where it is the second most 
common female malignancy.6   A study carried out in 
Punjab in the year 2014 showed cervical cancer as the 
third most common cancer among females in the 
province.18 Annual cancer registry report of Shaukat 
Khanum Cancer Hospital for the year 2016 also 
reported cervical cancer as the fourth most common 
female malignancy.13 The large geographical variation 
in the incidence of cervical cancer around the globe 
reflects the differences in the screening efforts and 
vaccination status against HPV infection.25  
Cancers of the kidney ranked third among females 
(7.6%), and fifth in males (5.6%). Majority of these 
cases were renal cell carcinomas, followed by 
urothelial carcinomas. Kidney cancers are associated 
with smoking, obesity, hypertension and chronic 
kidney diseases. Attention given to the avoidance of 
these risk factors may be helpful in decreasing the 
incidence of renal cancers. 
Skin cancers ranked third among males (16.3%), and 
fifth among females (7.1%). They were mainly 
squamous cell carcinomas and less frequently basal 
cell carcinomas. A previously carried out study in 
Rawalpindi, regarded skin as the second most 
common cancer site in both males as well as in 
females.14 
Colorectal carcinoma was the fourth most common 
type of cancer in males making up 5.6% of total male 
cases. In various local studies, colorectal cancers have 
been consistently reported among the leading cancers 
in males.13,14,17 Screening can detect colorectal polyps 
before they become cancerous and thus removal of 
these precancerous polyps comprises a treatment 
modality that is less extensive and more successful.26 
A brief account of the most common cancers 
encountered in our study has been given above. It is 
important to state that the findings of this study 
should be taken cautiously and cannot be extrapolated 
for the entire region due to referral and other biases 
regarding hospital data. The variations observed in the 
results of various local studies also reinforce the fact 
that the results of these hospital registry based studies 
should be followed cautiously and also that the 
establishment of proper population based cancer 
registries has become absolutely necessary for 
obtaining credible information about cancer 
prevalence in our country.  
Conclusion: 
In conclusion, the cancer pattern revealed by this 
study provides valuable leads to cancer epidemiology 
in the region. The two most common cancer sites in 
males were urinary bladder (30.7%) and prostate 
(24.7%), whereas in females they were breast (36.2%) 
and cervix (8.6%). In Pakistan, there is a great 
deficiency of population based cancer registries, in the 
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absence of which studies like these may prove useful 
for health planning, future research and effective 
cancer control. 
 
Acknowledgements: 
The authors express their gratitude to Dr. Ammara 
Ijaz, Assistant Professor, Department of Pathology, 
BBH, for her continuous help and support without 
which this study would not have been possible. We 
would also like to thank Dr. Nadeem Ikram, Associate 
Professor, Department of Pathology, BBH, for his 
guidance during the initial stages of the study. 
 
References: 
1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, 
Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. 
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality 
Worldwide: IARC CancerBase No.11 [Internet]. Lyon, France: 
International Agency for Research on Cancer; 2013.              
             Available from: http://globocan.iarc.fr    [Accessed 
22nd January 2018]. 
2. Institute for Health Metrics and Evaluation (IHME). GBD 
Compare Data Visualization. Seattle, WA: IHME, University 
of Washington, 2016. Available from: 
http://vizhub.healthdata.org/gbd-compare [Accessed 25th 
January 2018]. 
3. Lozano R, Naghavi M, Foreman K, et al. Global and regional 
mortality from 235 causes of death for 20 age groups in 
1990 and 2010: a systematic analysis for the Global Burden 
of Disease Study 2010. Lancet 2013;380(9859):2095-2128. 
4. International Agency for Research on Cancer. Global 
Initiative for Cancer Registry Development. Available from: 
http://gicr.iarc.fr/.   [Accessed 30th January 2018]. 
5. International Classification of Diseases for Oncology, Third 
Edition, Topographical Codes, World Health Organization. 
Available from: http://codes.iarc.fr/topography   [Accessed 
11th January 2018]. 
6. American Cancer Society. Global Cancer Facts & Figures 3rd 
Edition. Atlanta: American Cancer Society; 2015. Available 
from: https://www.cancer.org/content/dam/cancer-
org/research/cancer-facts-and-statistics/global-cancer-
facts-and-figures/global-cancer-facts-and-figures-3rd-
edition.pdf      [Accessed 30th January 2018]. 
7. Stewart B. W. and Kleihues P. (Eds): World Cancer Report. 
IARCPress. Lyon 2003. Available from: 
http://www.iarc.fr/en/publications/pdfs-
online/wcr/2003/WorldCancerReport.pdf   [Accessed 3rd 
February 2018]. 
8. Mohammed, AZ & T Edino, S & Ochicha, Ochicha & Kuliya-
Gwarzo, Aisha & Samaila, AA.. Cancer in Nigeria: A 10-Year 
Analysis of the Kano Cancer Registry. Nigerian Journal of 
Medicine 2008;17(3):280-284. 
9. Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jemal A. 
International variations in bladder cancer incidence and 
mortality. Eur Urol 2014;66(1):59-73. 
10. Parkin DM. The global burden of urinary bladder cancer. 
Scand J Urol Nephrol Suppl 2008(218):12-20. 
11. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, 
Abnet CC. Association Between Smoking and Risk of Bladder 
Cancer Among Men and Women. JAMA 2011;306(7):737–
745. 
12. Parkin DM. The global health burden of infection-associated 
cancers in the year 2002. Int J Cancer 2006;118(12):3030-
3044. 
13. Mahmood S. Annual cancer registry report-2016. Shaukat 
khanum.org; 2016; 1-21. Available from: 
http://shaukatkhanum.org.pk/wp-
content/uploads/2015/06/acrr-2016.pdf  [Accessed 4th 
February 2018]. 
14. Jamal S, Moghal S, Mamoon N, Mushtaq S, Luqman M, 
Anwar M. The pattern of malignant tumours: tumour 
registry data analysis, AFIP, Rawalpindi, Pakistan (1992-
2001). J Pak Med Assoc 2006;56(8):359-62. 
15. Ahmad S, Qureshi N. First cancer statistics report from 
hazara division. J Ayub Med Coll Abbottabad 2013;25:1-2. 
16. Islami F, Moreira DM, Boffetta P, Freedland SJ. A Systematic 
Review and Meta-analysis of Tobacco Use and Prostate 
Cancer Mortality and Incidence in Prospective Cohort 
Studies. Eur Urol 2014;66(6):1054-64. 
17. Adnan N, Rasheed G, Nadeem S, et al. Hospital-Based Cancer 
Registry. Journal of Rawalpindi Medical College (JRMC) 
2017;21(4): 349-353. 
18. Masood K, Masood A, Zafar J, Shahid A, Kamran M. Trends 
and Analysis of Cancer Incidence for Common Male and 
Female Cancers in the Population of Punjab Province of 
Pakistan during 1984 to 2014. Asian Pacific Journal of 
Cancer Prevention 2015;16(13):5297-5304. 
19. Hanif M, Zaidi P, Kamal S, Hameed A. Institution-based 
cancer incidence in a local population in Pakistan: nine year 
data analysis. Asian Pac J Cancer PreV 2009;10(2):227-30. 
20. Z. Aziz, S. Sana, S. Saeed, M. Akram. Institution Based Tumor 
Registry from Punjab: Five Year Data Based Analysis. JPMA 
(Journal Of Pakistan Medical Association) 2003:53(8). 
21. Chlebowski RT. Nutrition and physical activity influence on 
breast cancer incidence and outcome. Breast 2013;22S2: 
S30-S37. 
22. Catsburg C, Miller AB, Rohan TE. Active cigarette smoking 
and risk of breast cancer. Int J Cancer 2015;136(9):2204-9. 
23. Dossus L, Boutron-Ruault MC, Kaaks R, et al. Active and 
passive cigarette smoking and breast cancer risk: results 
from the EPIC cohort. Int J Cancer 2014;134: 1871-1888. 
24. Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de 
Koning H. Breast cancer screening policies in developing 
countries: a cost-effectiveness analysis for India. J Natl 
Cancer Inst 2008;100:1290-1300. 
25. Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, 
Bray F. Worldwide trends in cervical cancer incidence: 
Impact of screening against changes in disease risk factors. 
Eur J Cancer 2013 Oct;49(15):3262-73 
26. H. Gilbert Welch, Douglas J. Robertson. Colorectal Cancer 
on the Decline — Why Screening Can’t Explain It All. N Engl 
J Med 2016; 374:1605-1607. 
 
